NASDAQ:KMDA
Kamada Ltd. Stock News
$5.75
+0.190 (+3.42%)
At Close: May 03, 2024
Kamada Ltd. (KMDA) Q4 2023 Earnings Call Transcript
02:22pm, Wednesday, 06'th Mar 2024
Kamada Ltd. (NASDAQ:KMDA) Q4 2023 Results Earnings Conference Call March 6, 2024 8:30 AM ET
Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024
07:00am, Wednesday, 28'th Feb 2024
REHOVOT, Israel, and HOBOKEN, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd.
Kamada: Kedrion Deal Locks In Growth
06:42pm, Friday, 08'th Dec 2023
Kamada is a profitable specialty plasma company with a strong balance sheet and significant capital available for investment. The company has announced an expanded commercial agreement for its anti-ra
REHOVOT, Israel, and HOBOKEN, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indic
These Israeli pharmaceutical stocks are down in the wake of Hamas attack
08:53am, Monday, 09'th Oct 2023
Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on Israel.
Kamada to Announce Second Quarter and First Half Ended June 30, 2023 Financial Results and Host Conference Call on August 16, 2023
07:00am, Wednesday, 09'th Aug 2023
REHOVOT, Israel and HOBOKEN, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indica
Kamada: Deep Dive Following FIMI Placement, Rate Buy
05:10am, Wednesday, 21'st Jun 2023
Kamada Ltd. has potential catalysts for growth, capital attraction and regulatory tailwinds. The company's valuation appears attractive, with forward estimates suggesting a possible re-rating. Key ris
Kamada Ltd. (KMDA) Q1 2023 Earnings Call Transcript
01:21pm, Wednesday, 24'th May 2023
Kamada Ltd. (NASDAQ:KMDA ) Q1 2023 Results Earnings Conference Call May 24, 2023 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors, LLC Amir London - Chief Executive
Kamada to Announce First Quarter 2023 Financial Results and Host Conference Call on May 24, 2023
07:00am, Wednesday, 17'th May 2023
REHOVOT, Israel and HOBOKEN, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicat
Kamada Ltd. (KMDA) Q4 2022 Earnings Call Transcript
04:07pm, Wednesday, 15'th Mar 2023
Kamada Ltd. (NASDAQ:KMDA ) Q4 2022 Earnings Conference Call March 15, 2023 8:30 AM ET Company Participants Troy Williams - LifeSci Advisors Amir London - CEO Chaime Orlev - CFO Conference Call Partici
New Strong Buy Stocks for November 28th
09:02am, Monday, 28'th Nov 2022
KMDA, SLCA and FTNT have been added to the Zacks Rank #1 (Strong Buy) List on November 28, 2022.
Kamada Ltd. (KMDA) Q3 2022 Earnings Call Transcript
10:35am, Tuesday, 22'nd Nov 2022
Kamada Ltd. (NASDAQ:KMDA ) Q3 2022 Earnings Conference Call November 22, 2022 8:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Amir London - Chief Executive Officer Chaime Orlev - Chief Fi
Kamada (KMDA) Q3 Earnings and Revenues Top Estimates
09:47am, Tuesday, 22'nd Nov 2022
Kamada (KMDA) delivered earnings and revenue surprises of 433.33% and 8.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Kamada Ltd. (KMDA) CEO Amir London on Q2 2022 Results - Earnings Call Transcript
01:58pm, Wednesday, 17'th Aug 2022
Kamada Ltd. (NASDAQ:KMDA ) Q2 2022 Earnings Conference Call August 17, 2022 8:30 AM ET Company Representatives Amir London - Chief Executive Officer Chaime Orlev - Chief Financial Officer Bob Yedid -
Kamada (KMDA) Q2 Earnings Beat Estimates
09:47am, Wednesday, 17'th Aug 2022
Kamada (KMDA) delivered earnings and revenue surprises of 450% and 1.59%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
